Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine.

Riede, O; Seifert, K; Oswald, D; Endmann, A; Hock, C; Winkler, A; Salguero, FJ; Schroff, M; Croft, SL; Juhls, C; (2015) Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine. Gene therapy, 22 (8). pp. 628-35. ISSN 0969-7128 DOI: https://doi.org/10.1038/gt.2015.35

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1038/gt.2015.35

Abstract

Share

Download

Filename: gt201535a.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar